• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.老年多病共存患者药物治疗评估的结局优先级工具:一项全科医疗的试点研究
Br J Gen Pract. 2017 Jul;67(660):e501-e506. doi: 10.3399/bjgp17X690485. Epub 2017 Mar 27.
2
Eliciting Preferences of Multimorbid Elderly Adults in Family Practice Using an Outcome Prioritization Tool.使用结果优先级工具引出家庭医疗中患有多种疾病的老年人的偏好。
J Am Geriatr Soc. 2016 Nov;64(11):e143-e148. doi: 10.1111/jgs.14415. Epub 2016 Sep 9.
3
Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care.全科医疗中患有多重用药的老年人的药物管理策略:一项关于基层医疗处方行为的定性研究
Br J Gen Pract. 2016 Aug;66(649):e540-51. doi: 10.3399/bjgp16X685681. Epub 2016 Jun 6.
4
Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel.改善多重疾病状态下的药物管理:运用行为改变轮开发多重疾病协作药物审查与决策制定(MY COMRADE)干预措施
Implement Sci. 2015 Sep 24;10:132. doi: 10.1186/s13012-015-0322-1.
5
Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.在初级保健中支持多病共存和大量用药的老年人处方(SPPiRE):一项集群随机对照试验方案和试点研究。
Implement Sci. 2017 Aug 1;12(1):99. doi: 10.1186/s13012-017-0629-1.
6
Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).一项试点研究,旨在测试在基层医疗中对多重疾病的多重用药进行优先排序的试验设计和复杂干预措施(PRIMUMpilot)的可行性。
BMJ Open. 2016 Jul 25;6(7):e011613. doi: 10.1136/bmjopen-2016-011613.
7
Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.老年多病共存和使用多种药物的患者在全科医疗中所开药物的变化
BMC Fam Pract. 2018 Jul 28;19(1):131. doi: 10.1186/s12875-018-0825-3.
8
Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.慢性病中的多重用药——通过电子决策支持减少老年人群不适当用药和药物不良事件(PRIMA-eDS):一项随机对照试验的研究方案
Trials. 2016 Jan 29;17:57. doi: 10.1186/s13063-016-1177-8.
9
GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.全科医生管理多病共存患者的多种药物治疗和治疗困境:法国全科医生的横断面调查。
Br J Gen Pract. 2019 Apr;69(681):e270-e278. doi: 10.3399/bjgp19X701801. Epub 2019 Feb 25.
10
Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.一项综合干预措施对基层医疗中多重疾病患者多重用药优先排序(PRIMUM)的效果:一项实用整群随机对照试验的结果
BMJ Open. 2018 Feb 24;8(2):e017740. doi: 10.1136/bmjopen-2017-017740.

引用本文的文献

1
Impact of eliciting treatment priorities on analgesic prescribing in older patients with high levels of polypharmacy.引出治疗优先级对多重用药老年患者镇痛药物处方的影响。
Fam Pract. 2025 Jun 4;42(4). doi: 10.1093/fampra/cmaf056.
2
Structured medication reviews for patients with polypharmacy in primary care: a cross-sectional study in North West London, UK.英国伦敦西北部针对基层医疗中服用多种药物患者的结构化药物评估:一项横断面研究
JRSM Open. 2025 Apr 1;16(4):20542704251325056. doi: 10.1177/20542704251325056. eCollection 2025 Apr.
3
How do people with multimorbidity prioritise healthcare when faced with tighter financial constraints? A national survey with a choice experiment component.患有多种疾病的人在面临更严格的经济限制时如何优先选择医疗保健?一项包含选择实验部分的全国性调查。
BMC Prim Care. 2025 Feb 27;26(1):57. doi: 10.1186/s12875-025-02738-9.
4
Health outcome priorities of people with multiple long-term conditions using the outcome prioritisation tool in the UK: A survey study and feasibility assessment.英国使用结果优先排序工具的多种长期疾病患者的健康结果优先事项:一项调查研究与可行性评估
PLoS One. 2024 Dec 31;19(12):e0301740. doi: 10.1371/journal.pone.0301740. eCollection 2024.
5
Cross-sectional study assessing health outcome priorities of older adults with multimorbidity at a primary care setting in Singapore.在新加坡的基层医疗机构中,对患有多种慢性病的老年人的健康结果重点进行横断面研究。
BMJ Open. 2023 Dec 11;13(12):e079990. doi: 10.1136/bmjopen-2023-079990.
6
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.针对多病共存和多种药物治疗的老年人减药:TAILOR 证据综合。
Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475.
7
Involving patients in medicines optimisation in general practice: a development study of the "PREparing Patients for Active Involvement in medication Review" (PREPAIR) tool.将患者纳入一般实践中的药物优化:“准备患者积极参与药物审查”(PREPAIR)工具的开发研究。
BMC Prim Care. 2022 May 20;23(1):122. doi: 10.1186/s12875-022-01733-8.
8
A pilot study to identify elderly patients with cognitive impairment for clinical pharmacist polypharmacy review in General Practice.一项在全科医疗中识别认知障碍老年患者以进行临床药师多重用药评估的试点研究。
Explor Res Clin Soc Pharm. 2021 Aug 26;3:100065. doi: 10.1016/j.rcsop.2021.100065. eCollection 2021 Sep.
9
Optimising prescribing practices in older adults with multimorbidity: a scoping review of guidelines.优化多病共存老年人的处方实践:指南的范围综述。
BMJ Open. 2021 Dec 14;11(12):e049072. doi: 10.1136/bmjopen-2021-049072.
10
"I must, and I can live with that": a thematic analysis of patients' perspectives on polypharmacy and a digital decision support system for GPs.“我必须这么做,而且我能接受”:对患者关于多重用药及全科医生数字决策支持系统观点的主题分析
BMC Fam Pract. 2021 Aug 21;22(1):168. doi: 10.1186/s12875-021-01517-6.

本文引用的文献

1
Eliciting Preferences of Multimorbid Elderly Adults in Family Practice Using an Outcome Prioritization Tool.使用结果优先级工具引出家庭医疗中患有多种疾病的老年人的偏好。
J Am Geriatr Soc. 2016 Nov;64(11):e143-e148. doi: 10.1111/jgs.14415. Epub 2016 Sep 9.
2
Time Trends in Prevalence of Chronic Diseases and Multimorbidity Not Only due to Aging: Data from General Practices and Health Surveys.慢性病和多重疾病患病率的时间趋势:不仅归因于老龄化,来自全科医疗和健康调查的数据
PLoS One. 2016 Aug 2;11(8):e0160264. doi: 10.1371/journal.pone.0160264. eCollection 2016.
3
Why do family doctors prescribe potentially inappropriate medication to elderly patients?为什么家庭医生会给老年患者开可能不适当的药物?
BMC Fam Pract. 2016 Jul 22;17:93. doi: 10.1186/s12875-016-0482-3.
4
Methods to reduce prescribing errors in elderly patients with multimorbidity.减少老年多病患者处方错误的方法。
Clin Interv Aging. 2016 Jun 23;11:857-66. doi: 10.2147/CIA.S80280. eCollection 2016.
5
Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity.使患者价值观在医疗保健中可见:评估多病共存背景下患者治疗优先级和偏好的工具的系统评价。
BMJ Open. 2016 Jun 10;6(6):e010903. doi: 10.1136/bmjopen-2015-010903.
6
Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder.患有心血管疾病的多重用药患者的临床用药评估及药学服务计划的意义。
Int J Clin Pharm. 2016 Aug;38(4):808-15. doi: 10.1007/s11096-016-0281-x. Epub 2016 Apr 6.
7
Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.停用潜在不适当的预防性心血管药物:患者和全科医生面临的障碍与促进因素
Ann Pharmacother. 2016 Jun;50(6):446-54. doi: 10.1177/1060028016637181. Epub 2016 Mar 3.
8
General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.全科医生对多病共存老年个体减药的见解:一项定性研究。
Int J Clin Pract. 2016 Mar;70(3):261-76. doi: 10.1111/ijcp.12780.
9
Reducing Polypharmacy from the Perspectives of General Practitioners and Older Patients: A Synthesis of Qualitative Studies.从全科医生和老年患者视角减少多重用药:定性研究综述
Drugs Aging. 2016 Apr;33(4):249-66. doi: 10.1007/s40266-016-0354-5.
10
Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.老年多重用药患者的临床用药评估:荷兰药物相关问题的横断面研究
Int J Clin Pharm. 2016 Feb;38(1):46-53. doi: 10.1007/s11096-015-0199-8. Epub 2015 Nov 23.

老年多病共存患者药物治疗评估的结局优先级工具:一项全科医疗的试点研究

Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.

作者信息

van Summeren Jojanneke Jgt, Schuling Jan, Haaijer-Ruskamp Flora M, Denig Petra

机构信息

Department of General Practice, University of Groningen, University Medical Center Groningen, the Netherlands.

Drug Utilisation Studies, University of Groningen, University Medical Center Groningen, the Netherlands.

出版信息

Br J Gen Pract. 2017 Jul;67(660):e501-e506. doi: 10.3399/bjgp17X690485. Epub 2017 Mar 27.

DOI:10.3399/bjgp17X690485
PMID:28347987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5565860/
Abstract

BACKGROUND

Several methods have been developed to conduct and support medication reviews in older persons with multimorbidity. Assessing the patient's priorities for achieving specific health outcomes can guide the medication review process. Little is known about the impact of conducting such assessments.

AIM

This pilot study aimed to determine proposed and observed medication changes when using an outcome prioritisation tool (OPT) during a medication review in general practice.

DESIGN AND SETTING

Participants were older patients with multimorbidity (aged ≥69 years) with polypharmacy (five or more chronic medications) from the practices of 14 GPs.

METHOD

Patients were asked to prioritise four universal health outcomes - remaining alive, maintaining independence, reducing pain, and reducing other symptoms - using an OPT. GPs used this prioritisation to review the medication and to propose and discuss medication changes with the patient. The outcomes included the proposed medication change as documented by the GP, and the observed medication change in the electronic health record at follow-up. Descriptive analyses were conducted to determine medication changes according to the prioritised health outcomes.

RESULTS

A total of 59 patients using 486 medications prioritised the four health outcomes. GPs proposed 34 changes of medication, mainly stopping, for 20 patients. At follow-up, 14 medication changes were observed for 10 patients. The stopping of medication (mostly preventive) was particularly observed in patients who prioritised 'reducing other symptoms' as most important.

CONCLUSION

Using an OPT leads mainly to the stopping of medication. Medication changes appeared to be easiest for patients who prioritised 'reducing other symptoms' as most important.

摘要

背景

已经开发了几种方法来对患有多种疾病的老年人进行并支持药物审查。评估患者实现特定健康结果的优先事项可以指导药物审查过程。关于进行此类评估的影响知之甚少。

目的

这项试点研究旨在确定在全科医疗的药物审查中使用结果优先排序工具(OPT)时建议的和观察到的药物变化。

设计与背景

参与者是来自14名全科医生诊所的患有多种疾病(年龄≥69岁)且使用多种药物(五种或更多种慢性药物)的老年患者。

方法

要求患者使用OPT对四个普遍的健康结果进行优先排序,即维持生命、保持独立、减轻疼痛和减轻其他症状。全科医生利用这种优先排序来审查药物,并与患者提出并讨论药物变化。结果包括全科医生记录的建议药物变化,以及随访时电子健康记录中观察到的药物变化。进行描述性分析以确定根据优先排序的健康结果的药物变化。

结果

共有59名使用486种药物的患者对这四个健康结果进行了优先排序。全科医生提出了34项药物变化建议,主要是让20名患者停药。在随访时,观察到10名患者有14项药物变化。在将“减轻其他症状”列为最重要的患者中尤其观察到停药情况(大多为预防性用药)。

结论

使用OPT主要导致停药。对于将“减轻其他症状”列为最重要的患者,药物变化似乎最为容易。